Impax Asset Management Group plc trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 38.1% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 1,035,969 shares of the medical research company’s stock after selling 638,988 shares during the quarter. Agilent Technologies makes up 1.4% of Impax Asset Management Group plc’s holdings, making the stock its 20th biggest holding. Impax Asset Management Group plc’s holdings in Agilent Technologies were worth $178,508,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the business. Signature Equity Partners LLC lifted its stake in shares of Agilent Technologies by 172.7% in the 3rd quarter. Signature Equity Partners LLC now owns 180 shares of the medical research company’s stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Livelsberger Financial Advisory purchased a new position in shares of Agilent Technologies in the 3rd quarter worth approximately $32,000. Markowski Investments bought a new position in shares of Agilent Technologies during the 2nd quarter valued at approximately $27,000. Keating Financial Advisory Services Inc. bought a new position in shares of Agilent Technologies during the 2nd quarter valued at approximately $31,000. Finally, Osterweis Capital Management Inc. bought a new position in shares of Agilent Technologies during the 2nd quarter valued at approximately $43,000.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. Piper Sandler raised their price target on Agilent Technologies from $150.00 to $160.00 and gave the stock a “neutral” rating in a research report on Friday, August 28th. Evercore boosted their price objective on shares of Agilent Technologies from $148.00 to $178.00 and gave the company an “outperform” rating in a research report on Wednesday, October 7th. TD Cowen increased their target price on shares of Agilent Technologies from $180.00 to $196.00 and gave the company a “buy” rating in a research note on Tuesday, October 13th. Royal Bank Of Canada raised their target price on shares of Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a report on Thursday, August 27th. Finally, Deutsche Bank assumed coverage on shares of Agilent Technologies in a report on Monday, October 26th. They issued a “buy” rating and a $190.00 target price for the company. Eighteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $181.45.
Get Our Latest Stock Analysis on A
Insider Buying and Selling
In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the sale, the director owned 4,924 shares in the company, valued at $745,395.12. This trade represents a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Agilent Technologies Trading Down 0.4%
A opened at $172.29 on Wednesday. The stock has a market cap of $48.58 billion, a price-to-earnings ratio of 28.53, a P/E/G ratio of 2.54 and a beta of 1.24. The stock’s 50 day moving average price is $169.37 and its 200-day moving average price is $138.58. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $182.99. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05.
Agilent Technologies (NYSE:A – Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The firm had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the prior year, the business posted $1.37 earnings per share. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities analysts forecast that Agilent Technologies, Inc. will post 6.20 EPS for the current year.
Agilent Technologies Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th were given a $0.2550 dividend. This represents a $1.02 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Tuesday, October 6th. Agilent Technologies’s dividend payout ratio is 20.08%.
About Agilent Technologies
Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.
See Also
- Five stocks we like better than Agilent Technologies
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
